Lung Neoplasms: all 7,334 studies
Page 55 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and PrognosisStatus unknownNCT01963533
- Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLCCompletedNCT01963351
- Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung CancerCompletedNCT01958372Phase 1
- Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung CancerCompletedNCT01956331
- Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant NsclcStatus unknownNCT01955421Phase 2
- Immune Response in Lung CancerCompletedNCT01955343
- Accountability for Cancer Care Through Undoing Racism and EquityCompletedNCT01954641Not applicable
- Hatha Yoga in Lung Cancer CouplesTerminatedNCT01952860Not applicable
- Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01951755
- Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung CancerCompletedNCT01951690Phase 2
- Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT01951469Phase 3
- Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung CancerCompletedNCT01950156Phase 1/2
- Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung CancerCompletedNCT01949701Phase 1/2
- Rapid Learning for Lung CancerCompletedNCT01949259
- Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary DiseaseCompletedNCT01949181Not applicable
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLCNo longer availableNCT01947608
- Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung CarcinomaStatus unknownNCT01947062Phase 3
- Time Trends in Waiting Times of NSCLC Patients.WithdrawnNCT01946490
- Treatment of Multifocal Lung AdenocarcinomaTerminatedNCT01946100Not applicable
- Value of Physical Capacity Tests in Lung CancerCompletedNCT01943578
- Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent DiseaseCompletedNCT01941303
- Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation TherapyTerminatedNCT01939210Not applicable
- Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerWithdrawnNCT01938456Phase 1
- Improving Management of Breathlessness in Patients With Lung CancerCompletedNCT01937637Not applicable
- Usefulness of Blood Biomarkers for Overall Survival in NSCLCCompletedNCT01936571
- Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line TreatmentCompletedNCT01934465
- Treatment of Early Stage Lung Cancer by VATS Versus OPEN LobectomyStatus unknownNCT01933828Not applicable
- Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.CompletedNCT01933568Phase 1
- CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT01931787Phase 1
- Analysis of Plasma Tumor DNA in Lung Cancer PatientsStatus unknownNCT01930474
- Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR MutationStatus unknownNCT01929200Phase 2
- Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in ChinaCompletedNCT01928836
- Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibWithdrawnNCT01928160Phase 2
- Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by ResectionStatus unknownNCT01926483Phase 2
- Early Cancer Detection Test - Lung Cancer ScotlandCompletedNCT01925625Not applicable
- Lung Cancer Information Study (LCIS-R01)CompletedNCT01924416Not applicable
- Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）CompletedNCT01924195Phase 2
- AUY922 in Patient With Stage IV NSCLCCompletedNCT01922583Phase 2
- Stereotactic Precision And Conventional Radiotherapy EvaluationStatus unknownNCT01920789Not applicable
- Image Discovering Early Lung Cancer ProjectStatus unknownNCT01914458Phase 2
- the Quality of Life Assessment of Lung Cancer Patients in ChinaStatus unknownNCT01914120
- Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCWithdrawnNCT01913067Phase 2
- INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung CancerCompletedNCT01911507Phase 1
- Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) PatientsTerminatedNCT01911325Phase 1
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung CancerCompletedNCT01909752Phase 2
- A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based ChemotherapyTerminatedNCT01904253Phase 2
- Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) ImmunotherapyStatus unknownNCT01902875
- Temozolomide as Maintenance Therapy in Small Cell Lung CancerStatus unknownNCT01900951Phase 2
- Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung CancerCompletedNCT01899989Phase 1
- Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung CancerTerminatedNCT01898156Phase 1/2
- Perioperative Rehabilitation in Operation for Lung CancerTerminatedNCT01893580Not applicable
- An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeCompletedNCT01893268
- Right Side of Heart Function After Lung SurgeryStatus unknownNCT01892800
- VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung CancerStatus unknownNCT01891708
- Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing StrategyStatus unknownNCT01891123Not applicable
- To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLCTerminatedNCT01888692
- CT in Diagnosing Patients With Lung CancerCompletedNCT01888510Not applicable
- A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) MutationCompletedNCT01887886Phase 3
- Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised StudyCompletedNCT01887795Phase 3
- Body Composition Analysis for Patient With Lung Cancer Using Computed Tomography Image AnalysisStatus unknownNCT01887769
- Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing SurgeryTerminatedNCT01886573Phase 1
- Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung CancerStatus unknownNCT01885754
- AZD8186 First Time In Patient Ascending Dose StudyCompletedNCT01884285Phase 1
- NovellusDx Cancer Early Detection Blood Test- Clinical TrialCompletedNCT01883388
- Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC PatientsStatus unknownNCT01882621Phase 3
- Exercise in Advanced Stage Lung Cancer PatientsCompletedNCT01881906Not applicable
- Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）Status unknownNCT01881516Phase 2
- A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01874678Not applicable
- A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung CancerStatus unknownNCT01872416Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the LungStatus unknownNCT01872403Phase 2
- Pulmonary Artery Energy Sealing for VATS ProcedureCompletedNCT01871597Not applicable
- CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung CancerTerminatedNCT01871480Phase 2
- Effect of Lung Cancer Diagnoses on Family BehaviorsCompletedNCT01862770
- A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung CancerCompletedNCT01862081Phase 1
- A Phase I Study of iPS Cell Generation From Patients With COPDCompletedNCT01860898Not applicable
- A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive BiomarkersStatus unknownNCT01860508Not applicable
- A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR MutationCompletedNCT01859026Phase 1
- SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or ChemoradiationCompletedNCT01855191
- The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung CancerStatus unknownNCT01852838
- Rapid Autopsy and Procurement of Cancer TissueTerminatedNCT01851395
- Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation TherapyTerminatedNCT01851161
- Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerCompletedNCT01850303Phase 3
- Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional RegimenStatus unknownNCT01850147Phase 2
- Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersCompletedNCT01846520Not applicable
- An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01844791Phase 2
- Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung CancerCompletedNCT01840150Not applicable
- Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung CancerCompletedNCT01839955Phase 1
- Oral Vinorelbine as Induction Chemotherapy Followed Concomitant ChemoradiotherapyCompletedNCT01839032Phase 2
- Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic PatientsCompletedNCT01837511
- Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung CancerCompletedNCT01837329Phase 1
- Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)CompletedNCT01837186
- Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility StudyCompletedNCT01836692Not applicable
- Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT01836679Phase 2
- Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive ChemoradiationWithdrawnNCT01836341Phase 1
- Circulating Tumor Cells in Non-Small Cell Lung CarcinomaCompletedNCT01830426
- Lung Cancer Vaccine Plus Oral Dietary SupplementCompletedNCT01829373Phase 1
- CTP Imaging of Lung CancerCompletedNCT01823094
- Vandetanib in Advanced NSCLC With RET RearrangementCompletedNCT01823068Phase 2
- Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung CancerTerminatedNCT01820325Phase 1
- Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®WithdrawnNCT01820091Phase 1